# FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide–platinum combination in patients with neuroendocrine carcinomas grade 3

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/folfiri-regimen-an-effective-second-line-chemotherapy-after-failure-of-etoposide/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Olivia Hentic,Pascal Hammel,Anne Couvelard,Vinciane Rebours,Maria Cristina Zappa,Maxime Palazzo,F Maire,Gaël Goujon,Ana Maria Ferreira Gillet,Patrick Lévy,Philippe Ruszniewski |
| Citations | 164 |
| DOI | 10.1530/erc-12-0002 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://erc.bioscientifica.com/downloadpdf/journals/erc/19/6/751.pdf |
| OpenAlex ID | https://openalex.org/W2169749676 |
| PMID | 22940375 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Olivia Hentic](https://scholariq.org/researchers/olivia-hentic/)
- [Philippe Ruszniewski](https://scholariq.org/researchers/philippe-ruszniewski/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.